{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-12T04:25:31.071052+00:00","published_at":"2026-10-12T02:56:29.077205+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:mfm9z31aj2gi5","event_type":"GC_CHANGED","effective_at":"2026-03-05","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:brian-t-crum","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:48351126989a1f9050e815dc3a7c5a5590c97808cca94478ebeb26cfe10dcf49"],"summary":"Brian T. Crum executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1g8a5jy1wkmqh0","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-05","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:craig-b-granowitz-m-d-ph-d","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:a80cd2ca439437d991f1a36a53a5a8c8e499eaa87367ef95d51510459185a06d"],"summary":"Craig B. Granowitz, M.D., Ph.D. executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mbcwo31hnotnp","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-05","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:lisa-m-defrancesco","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:fc4df8a67d466cb52f4e44a73ec8d21378aac615086ef68b79dbacfb577fbff9"],"summary":"Lisa M. DeFrancesco executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:195r3ym1f1yzw0","event_type":"CEO_CHANGED","effective_at":"2026-03-05","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:michael-s-exton-ph-d","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:b1920fd7f205247534925401074b47a3bceab3c9a6b7ff0cc574e26493f11971"],"summary":"Michael S. Exton, Ph.D. executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:147x1f9q2ijaz","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-05","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:rachel-y-martens","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:9eff99ddff19a655ffae85b498c0762cab7132875988233d6486ec1279e6f5cc"],"summary":"Rachel Y. Martens executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ihc0g68pa9kc","event_type":"CFO_CHANGED","effective_at":"2026-03-05","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:scott-m-coiante","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:05ac497613ce0ea726a5a78fa7cc6cc4840ccd230d7b54c23525860c90ce3464"],"summary":"Scott M. Coiante executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:137xo5ggoqama","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-05","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:suma-gopinathan-m-s-ph-d","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:ff8f23fa6cce525eb1a943dd708a4bcf18320f34f61b032b729efd8923fa8ad2"],"summary":"Suma Gopinathan, M.S., Ph.D. executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:71j1ad1qdlibz","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-05","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:william-r-mcdermott","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:1fbb5ffffe3010c7f4915fc4a348addcce7e51ab8964e98ba72aeb46dded5fa5"],"summary":"Wendy E. McDermott executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1amw1n9qle1pb","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:ivan-h-cheung","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d"],"summary":"Ivan H. Cheung seat on LEXICON PHARMACEUTICALS, INC., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:164k9mgwdffhw","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:michael-s-exton-ph-d","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d"],"summary":"Michael S. Exton, Ph.D. seat on LEXICON PHARMACEUTICALS, INC., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mzba1t1lw64rx","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:diane-e-sullivan","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d"],"summary":"Diane E. Sullivan seat on LEXICON PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:r84iach5u9si","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:diane-e-sullivan","alpha:committee:lexicon-pharmaceuticals-inc:audit"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_record:20"],"evidence_ids":["alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b"],"summary":"Diane E. Sullivan member of Audit, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:b1278u7riud0","event_type":"DIRECTOR_APPOINTED","effective_at":"2007-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:christopher-j-sobecki","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d"],"summary":"Christopher J. Sobecki seat on LEXICON PHARMACEUTICALS, INC., effective 2007-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bhalqa264a94","event_type":"DIRECTOR_APPOINTED","effective_at":"2007-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:philippe-j-amouyal","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d"],"summary":"Philippe J. Amouyal seat on LEXICON PHARMACEUTICALS, INC., effective 2007-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:b6potw1r51lss","event_type":"DIRECTOR_APPOINTED","effective_at":"2007-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:raymond-debbane","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d"],"summary":"Raymond Debbane seat on LEXICON PHARMACEUTICALS, INC., effective 2007-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:dazw9yl7oy4i","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2007-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:philippe-j-amouyal","alpha:committee:lexicon-pharmaceuticals-inc:compensation"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_record:23"],"evidence_ids":["alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b"],"summary":"Philippe J. Amouyal member of Compensation, effective 2007-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:vnzdwe34rmk2","event_type":"DIRECTOR_APPOINTED","effective_at":"2000-01-01","detected_at":"2026-10-12T02:56:29.077205+00:00","subject_ids":["alpha:person:samuel-l-barker-ph-d","alpha:company:481f3104-140b-4121-9055-f6803dba7825"],"caused_claim_ids":["alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d"],"summary":"Samuel L. Barker, Ph.D. seat on LEXICON PHARMACEUTICALS, INC., effective 2000-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:5","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christopher-j-sobecki","object_label":"Christopher J. Sobecki","object_source_name_forms":[],"value":"Christopher J. Sobecki: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christopher-j-sobecki","name":"Christopher J. Sobecki"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2007-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2007-01-01","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2007-01-01","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:6","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:diane-e-sullivan","object_label":"Diane E. Sullivan","object_source_name_forms":[],"value":"Diane E. Sullivan: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:diane-e-sullivan","name":"Diane E. Sullivan"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:7","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ivan-h-cheung","object_label":"Ivan H. Cheung","object_source_name_forms":[],"value":"Ivan H. Cheung: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ivan-h-cheung","name":"Ivan H. Cheung"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:8","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-s-exton-ph-d","object_label":"Michael S. Exton, Ph.D.","object_source_name_forms":[],"value":"Michael S. Exton, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-s-exton-ph-d","name":"Michael S. Exton, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:9","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:philippe-j-amouyal","object_label":"Philippe J. Amouyal","object_source_name_forms":[],"value":"Philippe J. Amouyal: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:philippe-j-amouyal","name":"Philippe J. Amouyal"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":false,"start_date":"2007-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2007-01-01","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2007-01-01","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:10","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:raymond-debbane","object_label":"Raymond Debbane","object_source_name_forms":[],"value":"Raymond Debbane: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:raymond-debbane","name":"Raymond Debbane"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2007-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2007-01-01","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2007-01-01","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:11","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:samuel-l-barker-ph-d","object_label":"Samuel L. Barker, Ph.D.","object_source_name_forms":[],"value":"Samuel L. Barker, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:samuel-l-barker-ph-d","name":"Samuel L. Barker, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2000-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2000-01-01","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2000-01-01","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:12","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:brian-t-crum","object_label":"Brian T. Crum","object_source_name_forms":[],"value":"Brian T. Crum: Senior Vice President and General Counsel","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:brian-t-crum","name":"Brian T. Crum"},"title":"Senior Vice President and General Counsel","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:48351126989a1f9050e815dc3a7c5a5590c97808cca94478ebeb26cfe10dcf49","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:58.016831+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:13","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:craig-b-granowitz-m-d-ph-d","object_label":"Craig B. Granowitz, M.D., Ph.D.","object_source_name_forms":[],"value":"Craig B. Granowitz, M.D., Ph.D.: Senior Vice President and Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:craig-b-granowitz-m-d-ph-d","name":"Craig B. Granowitz, M.D., Ph.D."},"title":"Senior Vice President and Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:a80cd2ca439437d991f1a36a53a5a8c8e499eaa87367ef95d51510459185a06d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:59.363372+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:14","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lisa-m-defrancesco","object_label":"Lisa M. DeFrancesco","object_source_name_forms":[],"value":"Lisa M. DeFrancesco: Senior Vice President, Investor Relations and Corporate Communications","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:lisa-m-defrancesco","name":"Lisa M. DeFrancesco"},"title":"Senior Vice President, Investor Relations and Corporate Communications","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:fc4df8a67d466cb52f4e44a73ec8d21378aac615086ef68b79dbacfb577fbff9","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:58.478227+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:15","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-s-exton-ph-d","object_label":"Michael S. Exton, Ph.D.","object_source_name_forms":[],"value":"Michael S. Exton, Ph.D.: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-s-exton-ph-d","name":"Michael S. Exton, Ph.D."},"title":"Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:b1920fd7f205247534925401074b47a3bceab3c9a6b7ff0cc574e26493f11971","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:57.080658+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:16","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:rachel-y-martens","object_label":"Rachel Y. Martens","object_source_name_forms":[],"value":"Rachel Y. Martens: Senior Vice President, Partnerships and Corporate Strategy","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:rachel-y-martens","name":"Rachel Y. Martens"},"title":"Senior Vice President, Partnerships and Corporate Strategy","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:9eff99ddff19a655ffae85b498c0762cab7132875988233d6486ec1279e6f5cc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:59.800834+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:17","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:scott-m-coiante","object_label":"Scott M. Coiante","object_source_name_forms":[],"value":"Scott M. Coiante: Senior Vice President and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:scott-m-coiante","name":"Scott M. Coiante"},"title":"Senior Vice President and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:05ac497613ce0ea726a5a78fa7cc6cc4840ccd230d7b54c23525860c90ce3464","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:57.550194+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:18","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:suma-gopinathan-m-s-ph-d","object_label":"Suma Gopinathan, M.S., Ph.D.","object_source_name_forms":[],"value":"Suma Gopinathan, M.S., Ph.D.: Senior Vice President, Discovery","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:suma-gopinathan-m-s-ph-d","name":"Suma Gopinathan, M.S., Ph.D."},"title":"Senior Vice President, Discovery","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:ff8f23fa6cce525eb1a943dd708a4bcf18320f34f61b032b729efd8923fa8ad2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:58.897235+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:19","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:william-r-mcdermott","object_label":"Wendy E. McDermott","object_source_name_forms":[],"value":"Wendy E. McDermott: Senior Vice President, Human Resources","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:william-r-mcdermott","name":"Wendy E. McDermott"},"title":"Senior Vice President, Human Resources","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:document:1fbb5ffffe3010c7f4915fc4a348addcce7e51ab8964e98ba72aeb46dded5fa5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:07:00.290097+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_record:20","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair not stated; Members Diane E. Sullivan; Ivan H. Cheung","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":null,"members":[{"display_name":"Diane E. Sullivan","person_slug":"diane-e-sullivan","is_chair":false},{"display_name":"Ivan H. Cheung","person_slug":"ivan-h-cheung","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_record:23","subject_id":"alpha:company:481f3104-140b-4121-9055-f6803dba7825","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair not stated; Members Philippe J. Amouyal","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":null,"members":[{"display_name":"Philippe J. Amouyal","person_slug":"philippe-j-amouyal","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-12T02:56:29.077205+00:00","sources":[{"id":"alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:48351126989a1f9050e815dc3a7c5a5590c97808cca94478ebeb26cfe10dcf49","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:58.016831+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a80cd2ca439437d991f1a36a53a5a8c8e499eaa87367ef95d51510459185a06d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:59.363372+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:fc4df8a67d466cb52f4e44a73ec8d21378aac615086ef68b79dbacfb577fbff9","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:58.478227+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b1920fd7f205247534925401074b47a3bceab3c9a6b7ff0cc574e26493f11971","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:57.080658+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9eff99ddff19a655ffae85b498c0762cab7132875988233d6486ec1279e6f5cc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:59.800834+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:05ac497613ce0ea726a5a78fa7cc6cc4840ccd230d7b54c23525860c90ce3464","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:57.550194+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ff8f23fa6cce525eb1a943dd708a4bcf18320f34f61b032b729efd8923fa8ad2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:06:58.897235+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1fbb5ffffe3010c7f4915fc4a348addcce7e51ab8964e98ba72aeb46dded5fa5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LXRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T05:07:00.290097+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.85,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.892,"cross_source_agreement":0.75,"temporal_completeness":0.833},"diagnostics":{"published_claims":24,"factual_claims":24,"claims_with_linked_evidence":24,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":18,"temporal_claims_with_valid_from":15,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-12T02:56:29.077205+00:00","observed_at":"2026-10-12T02:56:29.077205+00:00","reviewed_at":"2026-10-12T02:56:29.077205+00:00","verified_at":"2026-10-12T02:56:29.077205+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":24,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/lexicon-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}